- Report
- March 2024
- 188 Pages
Global
From €3226EUR$3,374USD£2,772GBP
€3584EUR$3,749USD£3,080GBP
- Report
- May 2024
- 173 Pages
Global
From €4732EUR$4,950USD£4,067GBP
- Report
- December 2023
- 172 Pages
Global
€4775EUR$4,995USD£4,104GBP
- Report
- February 2024
- 110 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- May 2024
- 180 Pages
From €4684EUR$4,900USD£4,026GBP
- Report
- March 2022
- 120 Pages
Global
From €2390EUR$2,500USD£2,054GBP
- Report
- May 2023
- 100 Pages
Global
From €3500EUR$3,922USD£3,113GBP
The Arbovirus Testing market is a subset of the larger Infectious Disease Testing market. It is focused on the detection of arboviruses, which are a group of viruses transmitted by arthropods such as mosquitoes, ticks, and sandflies. These viruses can cause a range of illnesses, including dengue, chikungunya, Zika, and yellow fever. Arbovirus Testing is used to diagnose and monitor these diseases, as well as to track the spread of arboviruses in a given population.
Arbovirus Testing is typically performed using molecular techniques such as PCR and RT-PCR, as well as serological methods such as ELISA and immunofluorescence. These tests are available from a variety of companies, including Abbott, Bio-Rad, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more